Chargement de la couverture… Déplacer pour repositionner
MCV 5-dose implementation

MCV 5-dose implementation

Files
Timeline
About
Albums
Discussions
Events
Members
Announcements
Videos
Audio

Fichiers du groupe

10. Cross-country study on vaccine wastage in Ghana, Mozambique and Pakistan. Gavi webinar presentation with PATH, IQVIA and VillageReach. (17 May 2022)

Sassenach 12th July 2022 120

MCV 5-dose one-pager. Linksbridge/Sassenach, 2022.

Sassenach 12th July 2022 111

Abridged presentation of the MCV 5-dose opportunity for organizational stakeholders. Linksbridge/Sassenach (2022)

Sassenach 29th June 2022 104

Zero Dose Community of Practice MCV 5-dose presentation. Linksbridge/Sassenach, 2022

Sassenach 6th June 2022 200

MR 5-dose interview key findings. Linksbridge/Sassenach (2021)

Sassenach 6th June 2022 111

MR 5-dose Total Systems Effectiveness Analysis (TSE). Linksbridge/Sassenach (2021).

Sassenach 6th June 2022 187

Overview of Research and Resources on MR 5-dose. Linksbridge (2021)

Sassenach 6th June 2022 166

Report of the Regional Immunization Technical Advisory Group meeting. WHO AFRO, 2019.

Sassenach 6th June 2022 183

Ethiopia measles 5-dose study. CDC, WHO, JSI, Ethiopia MOH (2021)

Sassenach 6th June 2022 178

The value of tailoring vial sizes to populations and locations. Wedlock et al. (2018)

Sassenach 6th June 2022 166

The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia. John Snow Inc., Zambia MOH (2020)

Sassenach 6th June 2022 163

Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines. Wedlock et al. (2019)

Sassenach 6th June 2022 179

Health Care Worker Preferences and Perspectives on Doses per Container for 2 Lyophilized Vaccines in Senegal, Vietnam, and Zambia. Kanagat et al. (2020)

Sassenach 6th June 2022 162

Coverage, Cost, and Safety Impacts of Primary Container Choice. IVAC/Johns Hopkins (2013)

Sassenach 6th June 2022 107

Doses per vaccine vial container: An understated and underestimated driver of performance that needs more evidence. BMGF, JSI (2017)

Sassenach 6th June 2022 110

Implementing 5-dose Measles-Rubella Vaccine Vials in Zambia Research Findings. Dose Per Container Partnership, JSI (2019)

Sassenach 6th June 2022 105

Filtres